{"id":"https://openalex.org/W2018105695","doi":"https://doi.org/10.1331/japha.2009.08027","title":"Nonmedical use of prescription opioids and stimulants among student pharmacists","display_name":"Nonmedical use of prescription opioids and stimulants among student pharmacists","alternate_titles":[],"publication_year":2009,"publication_date":"2009-07-01","ids":{"openalex":"https://openalex.org/W2018105695","doi":"https://doi.org/10.1331/japha.2009.08027","mag":"2018105695","pmid":"https://pubmed.ncbi.nlm.nih.gov/19589764"},"language":"en","primary_location":{"id":"doi:10.1331/japha.2009.08027","doi":"https://doi.org/10.1331/japha.2009.08027","is_oa":false,"landing_page_url":"https://doi.org/10.1331/japha.2009.08027","pdf_url":null,"source":{"id":"https://openalex.org/S4210228861","display_name":"Journal of the American Pharmacists Association","issn_l":"1544-3191","issn":["1544-3191","1544-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Pharmacists Association","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2018105695"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062539034","display_name":"Sarah Lord","orcid":"https://orcid.org/0000-0001-6164-5476","observed_orcids":["https://orcid.org/0000-0001-6164-5476"]},"institutions":[{"id":"https://openalex.org/I1331203130","display_name":"National Development and Research Institutes","ror":"https://ror.org/00zfzef50","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1331203130"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sarah Lord","raw_affiliation_strings":["National Development and Research Institutes, Inc, New York, USA. lord@ndri.org","National Development and Research Institutes, Inc., , New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Development and Research Institutes, Inc, New York, USA. lord@ndri.org","institution_ids":["https://openalex.org/I1331203130"]},{"raw_affiliation_string":"National Development and Research Institutes, Inc., , New York, USA","institution_ids":["https://openalex.org/I1331203130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008166335","display_name":"George E. Downs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I110357561","display_name":"University of the Sciences","ror":"https://ror.org/048gmay44","country_code":"US","type":"education","lineage":["https://openalex.org/I110357561"]},{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I1331203130","display_name":"National Development and Research Institutes","ror":"https://ror.org/00zfzef50","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1331203130"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George Downs","raw_affiliation_strings":["Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA","institution_ids":["https://openalex.org/I110357561","https://openalex.org/I111088046","https://openalex.org/I1331203130","https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079194783","display_name":"Paul Furtaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I110357561","display_name":"University of the Sciences","ror":"https://ror.org/048gmay44","country_code":"US","type":"education","lineage":["https://openalex.org/I110357561"]},{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I1331203130","display_name":"National Development and Research Institutes","ror":"https://ror.org/00zfzef50","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1331203130"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Furtaw","raw_affiliation_strings":["Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA","institution_ids":["https://openalex.org/I110357561","https://openalex.org/I111088046","https://openalex.org/I1331203130","https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anamika Chaudhuri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I110357561","display_name":"University of the Sciences","ror":"https://ror.org/048gmay44","country_code":"US","type":"education","lineage":["https://openalex.org/I110357561"]},{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I1331203130","display_name":"National Development and Research Institutes","ror":"https://ror.org/00zfzef50","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1331203130"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anamika Chaudhuri","raw_affiliation_strings":["Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA","institution_ids":["https://openalex.org/I110357561","https://openalex.org/I111088046","https://openalex.org/I1331203130","https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085624751","display_name":"Amy Silverstein","orcid":"https://orcid.org/0000-0003-1213-2089","observed_orcids":["https://orcid.org/0000-0003-1213-2089"]},"institutions":[{"id":"https://openalex.org/I110357561","display_name":"University of the Sciences","ror":"https://ror.org/048gmay44","country_code":"US","type":"education","lineage":["https://openalex.org/I110357561"]},{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I1331203130","display_name":"National Development and Research Institutes","ror":"https://ror.org/00zfzef50","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1331203130"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy Silverstein","raw_affiliation_strings":["Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA","institution_ids":["https://openalex.org/I110357561","https://openalex.org/I111088046","https://openalex.org/I1331203130","https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033173589","display_name":"Arnold R. Gammaitoni","orcid":"https://orcid.org/0000-0002-4775-2862","observed_orcids":["https://orcid.org/0000-0002-4775-2862"]},"institutions":[{"id":"https://openalex.org/I110357561","display_name":"University of the Sciences","ror":"https://ror.org/048gmay44","country_code":"US","type":"education","lineage":["https://openalex.org/I110357561"]},{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I1331203130","display_name":"National Development and Research Institutes","ror":"https://ror.org/00zfzef50","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1331203130"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arnold Gammaitoni","raw_affiliation_strings":["Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA","institution_ids":["https://openalex.org/I110357561","https://openalex.org/I111088046","https://openalex.org/I1331203130","https://openalex.org/I27837315"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111891674","display_name":"Simon H. Budman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I110357561","display_name":"University of the Sciences","ror":"https://ror.org/048gmay44","country_code":"US","type":"education","lineage":["https://openalex.org/I110357561"]},{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]},{"id":"https://openalex.org/I1331203130","display_name":"National Development and Research Institutes","ror":"https://ror.org/00zfzef50","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1331203130"]},{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simon Budman","raw_affiliation_strings":["Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of College Health Programs, Inflexxion, Inc., Newton, MA, at the time this study was conducted; she is currently Principal Investigator, National Development and Research Institutes, Inc., New York. Professor of Clinical Pharmacy and Dean Emeritus, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia. Director of Student Health and Counseling, University of the Sciences in Philadelphia. Doctoral student in biostatistics, Boston University. Graduate student, School of Public Health, University of Michigan, Ann Arbor. Global Director of Scientific Affairs, Arthritis and Analgesics, Merck & Co., Inc., Whitehouse Station, NJ. CEO and President, Inflexxion, Inc., Newton, MA","institution_ids":["https://openalex.org/I110357561","https://openalex.org/I111088046","https://openalex.org/I1331203130","https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5062539034"],"corresponding_institution_ids":["https://openalex.org/I1331203130"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":5.6433,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.95404801,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"49","issue":"4","first_page":"519","last_page":"528"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11953","display_name":"Neuroethics, Human Enhancement, Biomedical Innovations","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonmedical-prescription-drug-use","display_name":"nonmedical prescription drug use","score":0.8560000061988831},{"id":"https://openalex.org/keywords/prescription-opioid-misuse","display_name":"prescription opioid misuse","score":0.8640000224113464},{"id":"https://openalex.org/keywords/stimulant-misuse","display_name":"stimulant abuse","score":0.9440000057220459},{"id":"https://openalex.org/keywords/pharmacy-students","display_name":"pharmacy students","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pharmd-students","display_name":"PharmD students","score":0.8790000081062317},{"id":"https://openalex.org/keywords/controlled-substances","display_name":"controlled substances","score":0.6039999723434448},{"id":"https://openalex.org/keywords/substance-use-prevalence","display_name":"substance use prevalence","score":0.5979999899864197},{"id":"https://openalex.org/keywords/academic-achievement","display_name":"academic performance","score":0.8889999985694885},{"id":"https://openalex.org/keywords/motives-for-drug-use","display_name":"motives for drug use","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8649381399154663},{"id":"https://openalex.org/C2777239462","wikidata":"https://www.wikidata.org/wiki/Q996839","display_name":"Fraternity","level":2,"score":0.7881889343261719},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.7530972957611084},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.6527069807052612},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5373017191886902},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.5063260793685913},{"id":"https://openalex.org/C2911204551","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Prescription Drug Misuse","level":5,"score":0.4603957533836365},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.4338147044181824},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4319992661476135},{"id":"https://openalex.org/C190385971","wikidata":"https://www.wikidata.org/wiki/Q373494","display_name":"Injury prevention","level":3,"score":0.4119781255722046},{"id":"https://openalex.org/C3017944768","wikidata":"https://www.wikidata.org/wiki/Q1450463","display_name":"Poison control","level":2,"score":0.40409448742866516},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.40176162123680115},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.2511916160583496},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.19206267595291138},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.14517194032669067},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12009987235069275},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000428","descriptor_name":"Alcohol Drinking","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001288","descriptor_name":"Attention","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004522","descriptor_name":"Educational Status","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006306","descriptor_name":"Health Surveys","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D010146","descriptor_name":"Pain","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010379","descriptor_name":"Peer Group","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011998","descriptor_name":"Recreation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012580","descriptor_name":"Schools, Pharmacy","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012907","descriptor_name":"Smoking","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013339","descriptor_name":"Students, Pharmacy","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D044465","descriptor_name":"White People","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D055553","descriptor_name":"Prescription Drugs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1331/japha.2009.08027","doi":"https://doi.org/10.1331/japha.2009.08027","is_oa":false,"landing_page_url":"https://doi.org/10.1331/japha.2009.08027","pdf_url":null,"source":{"id":"https://openalex.org/S4210228861","display_name":"Journal of the American Pharmacists Association","issn_l":"1544-3191","issn":["1544-3191","1544-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","medline","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Pharmacists Association","raw_type":"journal-article"},{"id":"pmid:19589764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19589764","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Pharmacists Association : JAPhA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W136555248","https://openalex.org/W1731735739","https://openalex.org/W1755857100","https://openalex.org/W1972490292","https://openalex.org/W1972770458","https://openalex.org/W1982529989","https://openalex.org/W1985483382","https://openalex.org/W1992736481","https://openalex.org/W2017303506","https://openalex.org/W2019810626","https://openalex.org/W2028682952","https://openalex.org/W2041057759","https://openalex.org/W2053707294","https://openalex.org/W2054317009","https://openalex.org/W2066607317","https://openalex.org/W2082491345","https://openalex.org/W2083480657","https://openalex.org/W2091456685","https://openalex.org/W2125971535","https://openalex.org/W2132471356","https://openalex.org/W2146653011","https://openalex.org/W2153162676","https://openalex.org/W2163050774","https://openalex.org/W2187808270","https://openalex.org/W2916025045"],"related_works":["https://openalex.org/W2890028540","https://openalex.org/W2921692009","https://openalex.org/W3165847314","https://openalex.org/W2808542319","https://openalex.org/W2162317381","https://openalex.org/W2743148699","https://openalex.org/W2153162676","https://openalex.org/W2164098679","https://openalex.org/W2088004285","https://openalex.org/W100158202"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2018105695","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
